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Since hepatitis B virus (HBV) infection can have serious sequelae, especially if infection occurs during childhood, there 
is a continuing need to examine its epidemiology so as to inform control measures.  We analyzed trends in disease 
incidence and patterns of hepatitis B virus (HBV) transmission in both Canadian-born and non-Canadian-born children 
from 1999 to 2003, through the Enhanced Hepatitis Strain Surveillance System. Amongst Canadian-born children, the 
incidence of newly identified HBV infection per 100,000 declined significantly during the study period from 1.4 in 1999, 
to 0.5 in 2003 (RR, 0.75 per year; 95% CI, 0.60-0.95). Amongst non-Canadian-born children, the incidence of HBV 
infection per 100,000 ranged from 9.4 to 16.3, during the study period (linear trend test, p=0.69). Poisson regression 
analysis revealed that non-Canadian-born children were more likely to have HBV infection (RR, 12.3; 95% CI, 7.6 to 
19.8), than Canadian-born children. HBV infection was found to be more common among children emigrating from high 
endemic area, than among Canadian-born children. Current Canadian immunization policy should take into 
consideration the protection of all children against HBV infection, including those coming from countries where mass 
hepatitis B vaccination programs have still not been launched.  
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1.  INTRODUCTION 
In certain parts of the world, Hepatitis B (HB) is a 
significant cause of chronic liver disease. It is estimated 
that more than 300 million adults and children worldwide 
are chronically infected with hepatitis B virus (HBV) [1]. 
Infections acquired in childhood are responsible for the 
largest majority of chronic HBV infection, with its 
attendant complications of cirrhosis and hepatocellular 
carcinoma [2]. Preventing HBV infection in young children 
is therefore of particular importance. 
There is a small amount of literature available on the 
prevalence of HBV infection in the general Canadian 
population. In previous studies of selected populations in 
Canada, HBV surface antigen (HBsAg) seroprevalence 
rates were estimated to be between 0.24% and 0.47% in 
people aged 14-30 years from a northern Ontario town [3]. 
These rates were estimated to be 5-15% in adults from 
Southeast Asia [4], and 0.1-0.5% in Canadian first-time 
blood donors [5]. In a 1995 survey of 1200 school children 
aged 8-10 years in Quebec, none were found to be positive 
for HBsAg, or the antibody to the HBV core antigen [6]. 
Since the early 1990s, an increasing number of immigrants 
from high and intermediate endemic areas have entered 
Canada [7]. This immigration may be changing the 
distribution of HBV infection in Canada.  
Since 1997, all provinces and territories in Canada 
have launched universal school-based vaccination 
programs in order to prevent HBV infection in the early 
years of life [8]. There is a continuing need to examine the 
effectiveness of the Canadian HBV vaccination strategy. 
Regarding the possible need for new HBV prevention 
strategy in Canada, the present study was therefore 
undertaken to analyze national Enhanced Hepatitis Strain 
Surveillance System (EHSSS) data collected from 1999 
through 2003.  
2.  METHODS 
Population and measures 
The detailed surveillance methods used in the EHSSS 
have been described elsewhere [9]. From 1999 to 2003, the 
number of health regions participating in the EHSSS has 
increased greatly; in 2003, 7 public health jurisdictions 
were participating. These health regions were distributed 
throughout the country, covering approximately 25% of 
the Canadian population (7.7 / 31 million total 
population), including approximately one third of all new 
immigrants to the country. Children with HBV infection, 
diagnosed between January 1, 1999 and December 31, 2003, 
were included in the analysis. For the purpose of this 
analysis, a child was defined as a person younger than 16 
years of age. This was calculated using the date for first 
positive test for HBsAg minus the date of birth. A newly 
identified case is a person who has a laboratory confirmed 
diagnosis of HBV infection for the first time. The diagnosis Int. J. Med. Sci. 2005 2 
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of HBV infection was based on positive HBsAg. The case 
definition for confirmed acute HBV infection includes the 
presence of HBsAg combined with IgM antibody to the 
HBV core (anti-HBc). A child was defined as Canadian-
born if the child’s birthplace was reported to be in Canada, 
or if the date of the mother’s immigration to Canada 
preceded the child’s date of birth. A person who did not 
meet these criteria was classified as non-Canadian-born. 
Virological laboratories, which were performing 
confirmatory testing for HB in each jurisdiction, either 
automatically reported or were contacted regularly for 
newly identified HB cases, laboratory test results, and 
other related information. A standardized data collection 
form was used. Information was obtained from basic 
demographic characteristics, diagnostic test results, 
presenting clinical syndromes, and basic epidemiologic 
information, including potential risk factors. Questionnaire 
data from all seven-health regions were entered into a 
longitudinal database for storage and analysis. Efforts were 
made to check the data records for accuracy and to 
eliminate any duplication. Audits were conducted at each 
3-month interval during the study period in order to 
evaluate completeness of reporting, and to capture any 
cases that were not initially identified. Missing values and 
irregularities were reassessed with the help of investigators 
at each health region. Programmed computer checks and 
cross-tabulations are used to reduce the risk of typing 
errors. 
Statistical methods 
SAS 8.2 statistical programs were used for analysis. 
The annual population estimates from the 2001 Canadian 
Census for birthplace classifications were used to calculate 
rates for newly identified HB cases in both Canadian-born 
and non-Canadian-born children [7]. Poisson regression 
analysis was used to compare the rates of the reported 
disease over time using: gender, calendar year, age and 
birthplace, which were the only variables available for 
denominator data. After examining the full model, we 
constructed the final model using a stepwise procedure. 
All possible interactions were considered, provided that a 
hierarchical model was maintained. A common reason for 
poorly fitting Poisson models is overdispersion of counts, 
which can result in overstating the statistical significance of 
differences between time periods [10]. To protect against 
this, significance levels were computed using a 
quasilikelihood estimation of the Poisson model, which 
included a dispersion parameter. To assess the adequacy of 
our models, we computed goodness-of-fit statistics on the 
residual deviance. Differences in proportions were 
determined by a chi-square test and, where necessary, 
Fisher’s exact test. The Kruskal-Wallis test was used to 
compare the ranked distribution of ordinal variables. Two-
tailed p values were reported where P<0.05 was considered 
statistically significant. 
3.  RESULTS 
From 1998 to 2003, a total of 197 newly diagnosed HB 
cases in children were reported to the EHSSS. Of these, 2 
clinically recognized HB cases with neither HBsAg nor IgM 
anti-HBc results were excluded. Thus, 195 HB cases in 
children were included in the final analysis. Of these 
children, 36 (18.5%) were Canadian-born, 156 (80.0%) were 
non-Canadian-born, and for 3 (1.5%) the birthplace was not 
reported. The 156 non-Canadian-born children came 
primarily from Asia (76.3%), with 19.9% from Africa, and 
3.8% from other areas. In all but four of the 195 children the 
infection was asymptomatic; the clinical characters of non-
Canadian-born children were similar with those of 
Canadian-born children. Nine out of the 195 children were 
identified as being infected with acute HBV. No significant 
statistical difference in the proportion of children with 
acute HBV infection was found between Canadian-born 
and non-Canadian-born children (Fisher’s exact test, 
p>0.2). The infection was diagnosed significantly earlier in 
Canadian-born children (median age 4 years) compared to 
non-Canadian-children (median age 13 years) (Kruskal 
Wallis test, p<0.01). Eight out of 75 possessed an aniline 
aminotransferase (ALT) level > 2 times the upper reference 
value of Canada (i.e., > 98 IU/L). The proportion of 
children with abnormal ALT did not reveal a significant 
difference between Canadian-born and non-Canadian-born 
children, at the time of diagnosis (Fisher’s exact test, p>0.1). 
In non-Canadian-born children, the mode of transmission 
was determined to be vertical in 17.3%, horizontal in 43.0%, 
and unknown in 37.7%. In the Canadian-born subgroup, 
horizontal transmission and neonatal maternal 
transmission were frequent (27.8%, and 63.9%, 
respectively), although in 8.3% of the cases the cause of 
infection was unknown.  
Table 1 illustrates the variation in rates of newly 
identified HBV infection through birthplace, age, gender, 
and year of reporting. Year-to-year trends in the rate of 
HBV infection in both Canadian-born and non-Canadian-
born children are shown in Fig. 1. Amongst Canadian-born 
children, the rate of newly identified HBV infection 
declined from 1.4 per 100,000 in 1999, to 0.5 per 100,000 in 
2003. This was statistically significant, with an estimated 
rate ratio (RR) for successive years of 0.75 [95% confidence 
interval (CI), 0.60-0.95; p=0.017]. Amongst non-Canadian-
born children, the rate of HBV infection per 100,000 ranged 
from 9.4 to 16.3 in the study period (test for linear trend, 
p=0.69).  
The final Poisson regression model included main 
effects for birthplace, age group, calendar year, an 
interaction term between age group and birthplace, and an 
interaction term between calendar year and birthplace on 
the RR scale. That is, the effect of both age and calendar 
year depended on a child’s birthplace. Gender was not 
retained, for its presence in the model did not affect the 
other coefficients. Table 2 illustrates rate ratios estimated 
from the model. After adjustment, the rate of HBV 
infection in non-Canadian-born children was 12.3 times 
higher than in Canadian-born children (95% CI 7.6-19.8). 
Among non-Canadian-born children aged 0-4 and 5-9 
years, the risk of acquiring HB, and being newly identified, 
was significantly lower than among those aged 10 to 15 
years (RR 0.18, 95% CI 0.11-0.28 and RR 0.17, 95% CI 0.11-
0.28, respectively). In contrast, compared with the baseline 
rate in Canadian-born children aged 10 to 15 years, 
Canadian-born children aged 0 to 4 years had a 3-fold 
greater risk of newly acquiring HBV infection (RR 3.56, 
95% CI 1.57-8.09).  
4.  DISCUSSION 
Within those health regions covered by the EHSSS, 
the Public Health Agency of Canada supports staff in 
conducting enhanced surveillance, intensive case 
investigations, and serologic follow-up. Therefore, it is 
reasonable to presume that the present surveillance 
captured most of the newly identified, clinically recognized Int. J. Med. Sci. 2005 2 
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cases with HBV infection in children. Furthermore, the 
present surveillance was carried out using a predefined 
operating protocol and predefined questionnaires for all 
seven health regions. The notification system was not 
materially changed during the study period, but 
augmented throughout by scrutiny of laboratory results 
and hospital admissions; therefore the incidence trend was 
not affected. Data collected through the EHSSS would 
provide valuable evidence of changes in secular trends 
over reasonably long time periods. They are useful in 
defining risk groups and monitoring changes in the 
population. 
Over the last 5 years, universal school-based 
vaccination strategies, as well as the increase in 
immigration flow and international adoptions, have 
changed the epidemiology of hepatitis occurring in 
childhood, in Canada. Our analyses of the EHSSS data 
collected during 1999-2003, suggest that these factors 
contribute to a reduced incidence of HBV infections in 
Canadian-born children, and to an unchanged incidence in 
non-Canadian-born children. Many non-Canadian born 
children in our study came from moderately or highly 
endemic countries, where the majority of the population is 
infected during childhood either perinatally or through 
child-to-child transmission [11, 12]. On a national scale, the 
influx of HB cases from endemic countries may currently 
be an important element in HB epidemiology in Canada, 
and may continue to be so in the foreseeable future. 
Nevertheless, amongst immigrant groups, improved social 
status or sociomedical integration, as well as the possibility 
of vaccination, particularly among children, could reduce 
the risk of household spread [13]. Given the strong 
association between place of birth, and the rate of reported 
HBV infection in children, it is suggested that focused 
screening for HBsAg in non-Canadian-born children may 
provide the means for detecting most HBsAg carriers with 
heretofore undiagnosed HB. Screening in these children for 
HBV is important for identifying those at risk of 
developing long-term consequences of chronic HBV 
infection, and for developing opportunities to vaccinate 
susceptible contacts to prevent further transmission [2]. 
One of the most striking results, occurring during the 
1999 to 2003 period, was the incidence of newly identified 
HBV infection, which decreased significantly in Canadian-
born children, particularly among children aged 10-15 
years. This trend of decrease is consistent with the results 
of an epidemiological survey in British Columbia, Canada, 
which demonstrates a significant decrease in the incidence 
of acute HBV infection in people aged 15 to 24 years [13]. A 
decrease in the incidence, observed in Canadian-born 
children, can be a result of the general improvement in the 
standard of living, hygiene, and the introduction of public 
health measures, such as refinement in blood screening, the 
use of universal precautions in a medical setting, and the 
implementation of universal school-based vaccination 
programs [8].  The incidence of acute HB in the general 
Canadian population has not increased, despite a growing 
number of chronic HBV-carrier s  [ 1 4 ,  1 5 ] .  T h e  r i s k  o f  
transmission may increase when the children with chronic 
HBV infection reach adulthood and establish sexual 
contacts. The analysis of our surveillance data supports the 
need for continuing universal childhood immunization in 
an attempt to prevent chronic HB and the associated 
substantial burden of HB-related chronic liver disease.  
The HBV screening and immunization guidelines 
have existed in Canada since the early 1990s to prevent 
perinatal transmission [8]. Regarding route of transmission, 
it is still noteworthy that a relatively high proportion of the 
newly identified HBV infection in Canadian-born children 
was attributable to perinatal transmission from a mother 
w i t h  H B V  i n f e c t i o n  d u r i n g  t h e  p a s t  f i v e  y e a r s .  I t  i s  
presumed that this is due to the recommended antenatal 
screening of pregnant women from risk groups, and the 
subsequent immunization of their newborns [16]. Infection 
in Canadian-born children seems to be primarily acquired 
through vertical transmission from the mother. This is in 
agreement with findings from other studies dealing with 
low endemic areas [17]. It is anticipated that the 
i d e n t i f i c a t i o n  o f  b a b i e s  a t  h i g h  r i s k  f o r  p e r i n a t a l  H B V  
infection will be more complete, and the administration of 
immunoprophylaxis at birth will become more routine. In 
data from the EHSSS, we found a relatively high rate of 
vertical and horizontal transmission in non-Canadian born 
children. This is consistent with the fact that most of the 
children came from highly endemic countries where 
vertical and horizontal transmission is the major route of 
virus acquisition [11, 18].  Cases amongst non-Canadian-
born children were on average older than cases amongst 
Canadian-born children (p<0.01). This could be due partly 
to the delay between infection and diagnosis in non-
Canadian-born children, although it would be interpreted 
that the age of acquiring HBV infection between the two 
groups of children may exist differently. In this study, it 
was not possible to estimate the number of HBV infections 
acquired in early life. Neither was it possible to estimate 
the number of children from this study who may have 
acquired infections occurring among them after they 
arrived in Canada, as the study was not designed to look at 
these factors. 
In our analyses, there are a number of limitations and 
potential sources of bias that may influence results, and 
therefore merit discussion. First, all of the analyses 
performed were based on the aggregate dataset from the 
EHSSS; thus the reported cases are likely to represent an 
underestimate of the true incidence of infection. This is due 
to the majority of childhood HB cases being asymptomatic. 
While these factors may affect the yearly incidence 
estimate, changes in the incidence rate would be reliable as 
long as the proportion of asymptomatic cases remained 
constant. We focused the analysis on all newly identified 
HB cases in children; therefore data collected through the 
EHSSS would provide valuable evidence of changes in 
secular trends over reasonably long time periods. Second, 
the ascertainment of infection would have been better 
among non-Canadian-born children. It is possible that 
immigrant family members were more likely to come to the 
attention of the reporting system, if patients were tested. 
The extent of ascertainment bias is likely to be minimal, for, 
as we know, Canada has not established a screening 
program for new immigrants. The study of our case series 
did not reveal differences in the severity of HBV disease 
between the two groups of children. Third, due to new 
immigrant migration to Canada from high endemic areas 
in recent years, there exists the expectation of a net increase 
in HB cases in children, generating a conservative bias. 
Fourth, only some cities (Vancouver, Edmonton, Calgary) 
with significant immigrant population, but not Montreal 
and Toronto, are part of this sentinel surveillance system. 
However, the EHSSS covers jurisdictions from coast to Int. J. Med. Sci. 2005 2 
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coast spanning Western Canada, the Prairies, Central 
Canada, and the Atlantic region, involving English-
speaking, French-speaking and other diverse ethnic 
populations. These regions cover a quarter of the Canadian 
population. 
In conclusion,  to prevent new HBV infections, it is 
important to ensure the screening of pregnant women, and 
the vaccination of children born to HBsAg-positive 
mothers. In addition, the immigrant population should be 
targeted for screening, education, and vaccination in order 
to reduce HBV transmission. Continued surveillance of 
HBV infection among children is necessary to implement 
future immunization strategies. 
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Tables 
Table 1. Rate ratio of newly identified HBV infection in children, 
EHSSS, 1999-2003 
Variable Incidence  rate 





Origins      
Non-Canadian born  13.80  16.23  8.36 to 31.53 
Canadian born  0.85  1#  
Year      
1999  5.24  1.94  0.51 to 7.40 
2000  4.34  1.60  0.43 to 5.90 
2001  4.80  1.77  0.50 to 6.24 
2002  2.53  0.93  0.23 to 3.72 
2003 2.71  1#  
Gender      
Male  3.94  1.19  0.51 to 2.75 
Female 3.32  1#  
Age (years)      
 0 to 4  2.71  1#  
 5 to 9  1.56  0.58  0.15 to 2.27 
10 to 15  6.06  2.24  0.84 to 5.97 
#Baseline group 
Table 2. The incidence rate ratios computed with multivariate 




interval for rate ratio 
Non-Canadian vs Canadian-born  12.27  7.60 to 19.81 
Calendar year for non-Canadian-born 
children 
0.98  0.87 to 1.10 
Calendar year for Canadian-born children  0.75  0.60 to  0.95 
0 to 4 years vs 10 -15 years for Canadian-
born children 
3.56  1.57 to  8.09 
5 to 9 years vs 10 -15 years for Canadian-
born children 
1.10  0.40  to 3.04 
0 to 4 years vs 10 -15 years for non-
Canadian-born children 
0.18  0.11 to 0.28 
5 to 9 years vs 10 -15 years for non-
Canadian-born children 
0.17  0.11 to 0.28 
*Poisson regression model adjusted for birthplace, age and calendar year, and 
interactions between birthplace and age, birthplace and calendar year. 
Figure 1. Annual rates of newly identified cases among children 
with HBV infection<16 years old, 1999 - 2003, by birthplace 
 